Benitec Biopharma Inc. (BNTC) stock
BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.54−0.50 (-5.53%)
Close on Nov 16, 2026Market cap $297.90MP/E –Yield –
Benitec Biopharma profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Benitec Biopharma's profit margin for the twelve months ending Mar 31, 2024 was -309885.7%. For fiscal 2023 it was -26082.7%, against -24942.5% the year before. The highest annual figure on record is 21.4% in fiscal 2019.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Jun 30, 2023 | -26082.7% | −1140.2 |
| FY2022 | Jun 30, 2022 | -24942.5% | −1413.7 |
| FY2021 | Jun 30, 2021 | -23528.8% | −15417.0 |
| FY2020 | Jun 30, 2020 | -8111.8% | −8133.2 |
| FY2019 | Jun 30, 2019 | 21.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -66585.7% | −47301.7 |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -8142.6% | +192007.4 |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -38650.0% | +352250.0 |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -6822.9% | +318377.1 |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -19284.0% | −14342.2 |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -200150.0% | −192642.9 |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -390900.0% | −388185.7 |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -325200.0% | −321724.2 |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -4941.8% | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -7507.1% | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -2714.3% | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -3475.8% | – |
See a number that looks wrong?